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25 pL of the hybridoma supernatent into rows A1-Al2, and is serially 
diluted 2-fold down the plate. The plate was allowed to incubate for 2 
h at 37 "C, which was then followed by a deionized water wash/shaking 
(10 times). All wells were next treated with 25 pL of a goat anti-mouse 
glucose oxidase (Cappel) solution, which was diluted previously 1500 in 
Blotto. The plate was allowed to incubate for 1 h at 37 "C. This was 
followed by ( lox)  deionized water wash/shaking. The plate is finally 
developed with 50 pL/well of a developing solution (25 mL, 0.2 M 
sodium phosphate, pH 6.0, 3 mL, 2Wb glucosc/deionized water, 200 pL, 
0.1% horseradish peroxidase/O.l M phosphate buffer, pH 6.0, 200 pL, 
ABTS (BMB)) (45 mg/mL of deionized water). After 30 min the plate 
(each well) absorbance was determined at 405 nm on a Molecular De- 
vices (V-) kinetic plate reader. 
A typical competition ELISA was performed in the following manner. 
A 'limiting" antibody and antigen concentration as determined above is 
used in the following manner. The BSA-hapten conjugate (concentration 
determined above) in PBS is added at 25 pL/well to an ELISA plate. 
Methanol fix was added at 50 pL/well for 5 min. The methanol is 
removed, and the plate is air-dried for 10 min. The plate is blocked as 
described above with Blotto (50 pL/well) at 37 "C for 30 min, and the 
excess Blotto is removed. Next, the antigen (hapten) or substrate (diluted 
1:20 in PBS-5% DMF) is serially diluted 2-fold (12 times). These 
solutions (12.5 pL) (each dilution) are added to the ELISA plate in the 
appropriate well, AI-Al2, followed by the antibody (concentration de- 
termined above) ( I  2.5 pL). This is allowed to incubate for 2 h at 37 "C. 
The plates are washed with deionized water (lox), and goat anti-mouse 
glucose oxidase is added (described above) followed by incubation for 1 
h at 37 "C. The plate is again washed with deionized water ( lox)  
followed by the addition of developing solution (described above). Ab- 
sorbances are read at 405 nm. 
The data (absorbances) obtained were fitted to eq 2 where CP is the 
absorbance determined and t is the antigen or substrate concentration. 
P( I ) ,  P(2), P(3), and care adjustable parameters in the four-parameter 
logistic fit.*' 
CP = p(l) + P(3) 
1 + P(2)tC 
Chemical Modification of Antibodies. (8) Pheayl@yox8l. A 50-pL 
aliquot of a phenylglyoxal solution (6 mM, 125 mM NaHCO,. pH 7.5) 
was added to buffer (195 pL; 125 mM, pH 7.5, NaHCO,) containing 
antibody (20 pM). The mixture was vortexed and left to stand for 1 h 
at room temperature. This was then transferred to a microdializer 
(Pierce) and d i a l i d  with 125 mM pH 7.5 NaHCO, with a flow-through 
of approximately 150 mL/h for 2 h. This was then flushed with 4 X 60 
mL portions of pH 8.4 50 mM CHES-100 mM NaCl and left to stand 
in this buffer overnight. This was again flushed 3 X 50 mL portions of 
pH 8.4 50 mM CHES-100 mM NaCl the next morning. Samples were 
removed, protein concentrations recalculated (BCA), and assays run for 
catalytic activity (HPLC) or binding (ELISA). A similar procedure was 
used with hapten present (200 pM). 
(b) Maleic Anhydride. A 5-pL aliquot of a maleic anhydride solution 
(0.06 M, dioxane) was added to 229 pL of 20 mM pH 8.0 borate100 
mM NaCl containing 20 pM of antibody. The solution was vortexed and 
left to stand at room temperature for I h. This was then transferred to 
a microdializer and dialyzed as described above with 50 mM phosphate, 
pH 7-100 mM NaCl overnight, followed by 50 mM CHES, pH 8.4-100 
mM NaCl for 2 h. Samples were removed, protein concentrations cal- 
culated (BCA), and assays run for catalytic activity or binding. 
(c) Diethyl Pyrocarbonnte. A IO-pL aliquot of a 0.6 M diethyl py- 
rocarbonate solution in ethanol is diluted in 1 mL of NaOAc (150 mM, 
pH 6-100 mM NaCI). Of this 5 pL is added to 229 pL of NaOAc (150 
mM, pH 6.0-100 mM NaCI) containing 20 pM of antibody. The mix- 
ture is vortexed and left to stand at 4 "C overnight. This was then 
transferred to a microdializer and dialyzed as described above with 
CHES (50 mM CHES, pH 8.4-100 mM NaCI). Samples were re- 
moved, protei.. concentrations determined (BCA), and assays performed 
for catalytic activity and binding. 
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Abstract: A coupled kinetic analysis of esperamicin, calicheamicin, and DNase I cleavage of covalently closed circular PM2 
DNA has been carried out. Analysis of the optical density data derived from agarose gel electrophoresis experiments shows 
that esperamicin A,, like the hydrolytic enzyme DNase I, produces mainly single-strand breaks in DNA. These agents cause 
covalently closed circular form I DNA to be initially converted to nicked circular form I1 DNA. However, the ratio of the 
rate constant for this process (k,') to that associated with conversion of form I1 to linear form I11 DNA ( k i )  is not consistent 
with completely random nicking, and some double-strand cleavage may occur. The values of k , ' / k i  found for DNase I and 
esperamicin A, were 5.4 nd 3.9, respectively. The behavior of these agents sharply contrasts with that of esperamicin C and 
calicheamicin, for which double-strand cleavage of DNA is deduced from the analysis. Although the rate constant for introducing 
the first break in DNA for calicheamicin is lower than the corresponding rate constant for esperamicin C, the second break 
(in the opposing strand) is fast for calicheamicin, making it the better double-strand cleaving agent. These drugs are unique 
among antitumor agents in that a single activation event on the warhead portion produces a double-strand break in DNA 
without the need to posttreat the DNA with other agents in order to induce a cleavage. The cleavage kinetics are discussed 
in terms of the structural differences in these unusual anticancer drugs. 
The newly discovered anticancer drugs esperamicin1*2 and 
calicheamicin3*' (Figure 1) exhibit high potency against murine 
tumor lines. These compounds possess sugar groups appended 
to an unusual 1,5-diyn-3-ene core structure referred to as the 
uwarheadn. In the presence of reducing agents and D N A  the 
warhead undergoes a rearrangement to create a phenylene di- 
radical that  causw strand breaks by attacking the sugar groups 
(1) Golik, J.; Clardy, J.; Dubay, G.; Groenewold, G.; Kawaguchi, H.; 
Konishi, M.; Krishnan, B.; Ohkuma, H.; Saitoh, K.4.; Doyle, T. W. J.  Am. 
Chcm. Soc. 1987. 109. 3461-3462. Golik. J.: Dubav. G.: Groenwold. 0.: 
Kawaguchi, H.; Konishi, M.; Krishnan. B.; Ohhma, H.i Saitoh, K.4.; Doyle; 
*TO whom correspondence should be a d d r d .  T. W. Ibid. 1987, 109, 3461-3462. 
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Figure 1. Structures of esperamicins AI and C and calicheamicin yt. 
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of DNA. An interesting feature of esperamicin and calicheamicin 
as well as the chromophore of neocarzino~tatin~ is that a single 
activation event produces 2 equiv of a species capable of reacting 
with sites on DNA, Le., the phenylene diradical. This raises the 
possibility that a single drug molecule, after activation, can react 
with opposing strands to produce a double-strand break in DNA. 
Since this type of lesion is more difficult to repair than a sin- 
gle-strand peak, it is possible that a high frequency of double- 
strand breaks in DNA may be part of the basis for the extreme 
cytotoxicity of this unusual class of antitumor agent. 
The evidence that esperamicin and calicheamicin cleave DNA 
via a double-strand process is primarily based on the drug-induced 
cleavage pattern on opposite DNA  strand^^.^ and in the case of 
calicheamicin on labeling experiments showing that both radicals 
of the phenylene diradical abstract hydrogen atoms from D N A 6  
In the absence of additional information such as the absolute rate 
processes for cleavage on both strands, it is not clear whether a 
single activated "warhead" produces lesions on opposing strands, 
Le., a double-strand peak, or whether the second peak is caused 
by a second drug binding to the nicked site and subsequently 
(2) Long, B. H.; Golik, J.; Forenza, S.; Ward, B.; Rehfuss, R.; Dabrowiak, 
J. C.; Catino, J. J.; Musial, S. T.; Brookshire, K. W.; Doyle, T. W. Proc. Narl. 
Acad. Sci. U.S.A. 1989, 86, 2-6. 
(3) Lee, M. D.; Dunne, T. S.; Siegel, M. M.; Chang, C. C.; Morton, G. 
0.; Borders, D. B. J. Am. Chem. Soc. 1987,109, 3464-3466. Lee, M. D.; 
Dunne, T. S.; Chang, C. C.; Ellestad, G. A.; Siegel, M. M.; Morton, G. 0.; 
McGahren, W. J.; Borders, D. B. Ibid. 1987, 109, 3466-3468. 
(4) Zein, N.; Sinha, A. M.; McGahren. W. J.; Ellestad, G. A. Science 
1988, 240, 1198-1201. Zein, N.; Poncin, M.; Nilakantan, R.; Ellestad, G. 
A. Ibid. 1989. 244, 697699. 
( 5 )  Goldberg, I. H. Free Radical Biol. Med. 1987, 3. 41. 
(6) Zein, N.; McGahren, W. J.; Morton, G. 0.; Ashcroft, J.; Ellestad, G. 
A. J .  Am. Chem. Soc. 1989, 111,6888-6890. 
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Figure 2. Photograph of agarose gel showing esperamicin C cleavage of 
P V 2  DNA. The drug concentration in the various lanes, in order of 
increasing drug concentration (left to right), can be found in the Ex- 
perimental Section. Lane 1 is zero drug concentration. The various 
forms of PM2 DNA, covalently closed circular (I), nicked circular (11), 
and linear (111). are shown on the right of the figure. 
causing a break in the opposite strand. In the case of neo- 
carzinostatin, a "double-strand" break is the result of a break in 
the sugar-phosphate backbone on one strand and the creation of 
an apurinic/apyrimidic site two nucleotides away from the initial 
break on the opposing DNA ~ t r a n d . ~  Treatment of the modified 
DNA with endonuclease IV or putrescine, agents that attack 
apurinic/apyrimidic sites, is necessary in order to cause the second 
break in DNA. 
In  this paper we examine the ability of esperamicins AI and 
C and calicheamicin 7;  to cleave closed circular PM2 DNA. The 
cleavage data are quantitatively analyzed with use of coupled 
kinetic models representing single- and double-strand cleavage 
processes. For comparative purposes, we also analyze cleavage 
of PM2 DNA by the hydrolytic enzyme DNase I under conditions 
previously reported to yield single-strand breaks in DNA.' 
PM2 DNA, a covalently closed circular DNA molecule that 
is 9300 nucleotides long, is a convenient substrate for studying 
the cleavage action of DNA-nicking drugs. An agent capable of 
binding to DNA and yielding 1 equiv of a DNA-damaging group 
from a single activation event would cause an initial break in the 
PM2 genome, leading to the loss of supercoiling and the formation 
of nicked circular form I 1  DNA. Subsequent binding and acti- 
vation events would cause additional nicking of form I1 DNA. 
If  two breaks on opposing DNA strands were relatively close to 
one another, the DNA segment between the breaks would "melt", 
causing form I1 to be converted to the linear form, form 111 DNA. 
Although DNA melting depends strongly on sequence as well as 
other  factor^,^ breaks on opposing strands up to 6-10 base pairs 
apart would likely cause linearization of the DNA molecule under 
the conditions used in this study. 
Experimental Section 
The esperamicins (esp) were obtained from J. Golik of Bristol-Myers 
Squibb Co., Wallingford, CT, while the sample of calicheamicin yf was 
obtained from G. Ellestad of Lederle Laboratories. Stock drug concen- 
trations (-3 X IOa M) were made by dissolving weighed amounts of 
the drugs, 1-3 mg, in ethanol. Dilutions necessary for the strand scission 
work were done by adding a portion of the ethanol stock to a larger 
volume of the aqueous buffer used in the study. The maximum con- 
centration of ethanol introduced by this procedure in any of the cleavage 
experiments was <I%.  All DNA concentrations are stated in base pairs. 
Cleavage of PM2 DNA. The cleavage of PM2 DNA by esperamicin 
and calicheamicin was carried out in a total volume of 13 pL at 37 OC 
for IO min in the buffer 6.2 mM Tris-HC1/0.6 mM EDTA, pH 7.5. To 
2 pL of the solution containing DNA was added 8 pL of a solution 
containing the drug, followed by 3 pL of the solution containing dithio- 
threitol (DTT). The final concentrations of PM2 DNA and DTT present 
in the reaction medium were 9.4 X M and 0.45 mM, respectively. 
Concentrations of csp A,: 0.9.23 X M; 1.38.4.62, 9.23 X 10-9 M; 
(7) Povirk, L.; Houlgrove, C. W.; Hau, J.-H. J. Biol. Chem. 1988, 263, 
(8) Campbell, V. W.; Jackson, D. A. J. Biol. Chem. 1980,255,3726-3735. 
(9) Marky, L. A.; Breslauer, K. J. Proc. Natl. Acad. Sci. U S A .  1W.84, 
19263- 19266. 
4359-4363. 
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Figure 3. Intensities for forms I, 11, and I11 DNA resulting from DNase 
I cleavage of PM2 DNA as a function of DNase I concentration. In- 
tensities calculated by the single-strand (A) and double-strand (B) models 
described in  the text are open symbols. Curves are fits to calculated 
intensities. 
1.39, 1.85, 4.62, 9.23 X M; 1.39, 1.87, 4.62 X M. Concen- 
trations of esp C: 0, 9.23 X 1WL0 M; 1.85, 4.62, 9.23 X IO4 M; 1.39, 
1.85, 4.62, 9.23 X lod M; 1.39, 1.85, 2.31, 4.62, 9.23 X lW7 M. Con- 
centrations of calicheamicin used in the study: 0.9.69 X 104 M; 1.38, 
4.62, 9.23 X IO4 M; 1.85, 4.62, 9.23 X M; 1.38, 1.85 X lod M. 
After a digest time of 10 min, the reaction was terminated by the addition 
of 4 pL of a 3 X IO-' M sodium dodecyl sulfate %top" solution, and the 
DNA was loaded onto a horizontal 0.8% agarose gel and electrophoresed. 
After electrophoresis, the gel was soaked in a 0.5 pg/mL solution of 
ethidium bromide for 1 h, placed on a UV transilluminator, and photo- 
graphed with use of a Polaroid camera equipped with positive/negative 
Type 55 film. The resulting negative was 'fixed" according to the 
manufacturer's recommendation with aqueous 18% Na2S0,. A photo- 
graph of the stained gel for esp C is shown in Figure 2. 
Cleavage of PM2 DNA was also carried out with use of DNase I in 
a total volume of 7 pL of the buffer 14.3 mM Tris-HC1/9.1 mM 
MgC12/2.3 mM CaCI2, pH 7.5. After proceeding for IO min, the reac- 
tion was terminated by addition of aqueous EDTA and the products were 
loaded onto an agarose gel. Concentrations of DNase I (units/pL) 
present in the various reactions: 1. I ,  1.67, 2.22, 5.56 X lo4; 1.1, 1.67, 
2.22, 5.56 X lW*; 1.1, 1.67, 2.22, 5.56 X IO-'; 1.1  X lod. 
A Molecular Dynamics Model 300A microdensitometer capable of 
whole-spot integration was used to scan the photographic negatives of the 
agarose gel data. Control experiments (data not shown) showed that 
measured densities on the negative were dependent on the placement of 
the gel relative to the optical axis of the camera and to a certain extent 
on the gel's location on the UV transilluminator. The intensity varied 
smoothly from a maximum in the center of the negative to minima at 
both edges. In order to correct for these experimental effects as well as 
errors due to loading slightly different amounts of DNA into the wells 
of the gel, the sum of the intensities of the three DNA forms for each 
111 -43' . b 
0 1 ' 1 1 8 '  . - r rnm. 7 ~ ' ~ * ~ f ,  8 7 1  
[Esperamicin], pM 
Figure 4. Intensities for forms I, 11, and I11 DNA resulting from es- 
peramicin AI cleavage of PM2 DNA as a function of concentration of 
esperamicin AI. See caption to Figure 3 for further details. 
I__- - -  .a 
0.0001 0.001 0.01 0.1 
lane was adjusted to a constant value. The maximum value of the cor- 
rection factor was 1.9. Lanes for which this type of correction would not 
be valid, Le., the lanes having the highest drug and DNase I concentra- 
tions, where significant amounts of short fragments were produced, were 
not used in the analysis. Although response of photographic film to 
ethidium bromide fluorescence has been reported to be nonlinear,I0 no 
correction for this effect was made. Gels containing differing amounts 
of stained DNA but photographed so as to minimize the illumination/ 
optic effects (see above) showed that any nonlinearity was minor over the 
density range studied. Because of its superhelical nature, the ability of 
form I DNA to stain under saturated ethidium bromide conditions was 
less than that of forms I1 and I11 DNA: the earlier determined factor 
of 0.8 was used to multiply calculated intensities of form I DNA (see 
below)." The experimental band intensities as a function of drug con- 
centration or units (DNase I) can be found in Figures 3-6. 
The band intensities are proportional to the amounts of the various 
forms of DNA present at the end of the digest period T (10 min). The 
kinetic models for the interconversion of the various forms of DNA arc 
discussed in the next section. Given such a model, one can calculate the 
amount of each DNA form for each concentration of cleavage agent, in 
terms of the rate constants and the amounts of the three forms present 
before reaction with cleavage agent. The rate constants and initial 
amounts are parameters determined by seeking the values that minimize 
the deviation between the experimental and calculated band intensities. 
Thus, if Il1,is the intensity of form i at t = T when the cleavage agent 
concentration is cl and if is the corresponding value calculated 
according to a model, we minimize 
D EE(1,, - I,jak)2 
I f  
(IO) Pruncll, A.; Straws, F. and Leblanc, E. Anal. Blochem. 1977, 78, 
( 1  1) Bauer, W.; Vinograd, J. J .  Mol. Blol. 1968, 33, 141-171. 
51-65. 
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Figure 5. Intensities for forms I, 11, and I11 DNA resulting from es- 
peramicin C cleavage of PM2 DNA as a function of concentration of 
esperamicin C. See caption to Figure 3 for further details. 
with respect to these parameters. The nonlinear minimization problem 
is solved by the Simplex Search Method.I2 With this iterative method, 
values of D arc calculated for several sets of values of the parameters. 
The calculated values of D indicate in what way the parameters should 
be changed to obtain lower values of D, and the process is repeated. 
Results and Discussion 
In the cases of esperamicin and calicheamicin, an activation 
agent has been postulated to produce a diradical possessing two 
DNA-damaging equivalents. If both radicals on the phenylene 
moiety reach DNA targets, strand scission will be a two-step 
kinetic process with reaction of one radical with a site on DNA, 
e.g., removing a hydrogen atom from deoxyribose, followed by 
the reaction of the second radical with another DNA site. (The 
likelihood of a concerted process, Le., identical reaction rates for 
the reaction of the two radicals, seems low since it would require 
optimal positioning of both radicals relative to their respective 
DNA targets.) If the drug did not move from its original position 
in the time required for both radicals of the phenylene moiety to 
react with DNA targets on opposing strands, the covalently closed 
circular form 1 DNA would be converted directly to form 111 DNA 
without passing through the nicked circular form I1 DNA. Al- 
though the rate constant of hydrogen atom abstraction of the 
phenylene diradical of esperamicin and calicheamicin from a donor 
has not been measured, studies on related systems suggest that 
this constant is large, ,106 M-' s-*, and thus the drug may not 
have time to migrate to a new position on DNA before hydrogen 
abstraction from some source occurs.13 If only one of the phe- 
(12) Fletcher, R. Pracrlcal Methods of Oprfmizarion; Wiley: Chichester, 
(13) Lockhart, T. P.: Comita, P. 9.; Bergman, R. G .  J .  Am. Chem. Soc. 
1980. 
1981, 103,40824090. 
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Figure 6. Intensities for forms I, 11, and 111 DNA resulting from Cali- 
cheamicin cleavage of PM2 DNA as a function of calichcamicin con- 
centration. See caption to Figure 3 for further details. 
nylene diradicals reacts with DNA or both react with the same 
strand of the polymer, form I would convert to form I1 DNA. 
Extensive random cleavage of the latter form would eventually 
produce the linear product, form 111 DNA. 
The experimental results of the studies involving PM2 D N A  
are shown in Figures 2-6, solid symbols. In the cases of DNAse 
I and esp AI (Figures 3 and 4), cleavage caused closed circular 
form I DNA to decrease in amount while at the same time nicked 
circular form I1 increased in amount. Higher concentrations of 
DNAse I or esp A led to a decrease in the amount of form I1 while 
linear form 111 DNA increased in amount. This behavior con- 
trasted with that of esp C and calicheamicin, which showed de- 
creases in the amount of form I with concomitant increases in the 
amount of form 111 DNA (Figures 5 and 6). These intensity/ 
concentration plots (Figures 3-6) were analyzed according to the 
single- and double-strand cleavage models given below. The 
calculated rate constants can be found in Table I. 
To model the interconversion of the three forms of PM2 DNA, 
we begin by assuming that the rate of nicking of each form of 
DNA is proportional to its concentration and to the concentration 
of the cleavage agent (DNAse I or drug). Each interconversion 
rate is proportional to the rate of nicking. Then, for example, 
the rate of decrease of the concentration of the closed circular 
form I DNA is d[I]/dt = -k,'[I][P] where kl' is a second-order 
rate constant and [PI is the concentration of cleavage agent. The 
experimental data for esperamicin and calicheamicin show that 
there is little or no change in the concentrations of the three forms 
of PM2 DNA over the digest time unless the drug concentrations 
exceed about 0.02 pM. Since the concentration of PM2 DNA 
(plasmid per unit volume) is only 0.01 pM, and since we believe 
almost all the drug is bound to the DNA, this implies that only 
a fraction of the drug is activated, so that the drug concentration 
5430 J.  Am. Chem. Sa., Vol. 113, No. 14, 1991 Kishikawa et al. 
Table I. Rate Constants for Esperamicin, Calicheamicin, and DNase I Cleavage of PM2 DNA 
cleavage anent model' k , ' b  k,' k,' k.r' D X IOsc  
DNase Id 
DNase Id 
esp AI 
esp AI 
esp C 
esp C 
calicheamicin 
calicheamicin 
ss 
ds 
ds 
ds 
ds 
ss 
ss 
ss 
0.49 f 0.07 
1.95 f 0.25 
0.31 f 0.03 
0.038 f 0.004 
0.46 f 0.20 
1.31 f 0.21 
0.31 f 0.03 
0.039 f 0.004 
0.09 f 0.03 
-0.05 f 0.03 
0.50 f 0.07 
-0.38 f 0.06 
0.94 f 0.10 
0.12 f 0.04 
2.51 f 1.5 
0.007 f 0.003 
0.11 f 0.03 
0.10 f 0.05 
0.07 f 0.08 
-0 .11  f 0.10 
0.09 f 0.007 
0.00 f 0.01 
0.015 f 0.010 
0.019 f 0.009 
1.4 
4.5 
6.9 
20.4 
1.2 
1.4 
0.047 
0.046 
a Model ss involves only single-strand cleavage, Le., form I - form I1 - form I11 DNA. Model ds is for double-strand cleavage, form I - form 
Ill and form I1 - form 111. bSccond-order rate constants in pM-' mi&. CThe quantity D is the sum of the squared deviations between experimental 
and calculated data. Stated errors are changes producing 10% increase in D. "For DNAse I, the rate constants are in (units/L)-' min-I. 
[PI remains essentially constant during the time of the digest. 
Therefore, all the rate laws are pseudo-first-order. For instance, 
we write d[I]/dr = -k,[I], where the pseudo-first-order rate 
constant k ,  is kl' multiplied by [PI. 
Single-Strand Cleavage Model. We first consider that the 
nicking process converts closed circular DNA, form I, to nicked 
circular DNA, form 11, with a rate constant of kl .  Subsequent 
nicking converts form I1 to linear DNA (form 111) with a rate 
constant of k2. Further cleavage of form 111 converts it to un- 
detected forms of DNA with a rate constant of k3 (including all 
processes that destroy form 111 DNA). The rate laws are  then 
d[III] 
dr 
- =  k2[II] - k3[III] 
Integrating these expressions, we have 
Here, Co, No, and l, are, respectively, the initial values of [I], 
[II], and [III]. The DNA used in this investigation included forms 
I1 and I11 DNA in addition to form I DNA so No and L, are not 
zero. For t in these expressions we will use the digest time 7 (10 
min), and for k,, the true rate constant, k[ multiplied by the 
concentration of cleavage agent. 
Doubk-Strmd Cleavage Model. Another possibility is that the 
cleavage agent, nicking the closed circular DNA, converts it 
directly to the linear form, ;.e., form I - form 111. This is termed 
a double-strand.break. The rate laws are then 
The linear form can be produced from the nicked form, or directly 
from form I. Integrating these equations, we obtain 
where Co, No, and 4 are  the initial concentrations of the three 
forms and 
a k4CO/(k3 - k4) fi  = k2NO/(k3 - k2) 
There are, as in the previous model, six parameters: three rate 
constants and three initial concentrations. 
Derivation of Rate Constants. For either of the two models, 
the amounts or intensities of all three forms may be calculated 
for all drug or DNase I concentrations in terms of six parameters: 
three rate constants and three initial concentrations (Co, No, 4). 
For any set of values for these parameters, calculated intensities 
may be compared with the experimental intensities. The pa- 
rameters are varied to minimize the sum of the squared deviations: 
D = x(Iij - Zua'c)2. Here, Zii is the intensity of form i when the 
drug or DNase I concentration is cis The values of the second- 
order rate constants found by minimization of D, for each model 
and for each cleavage agent, are given in Table I, along with the 
minimum values of D. In Figures 3-6, we show the intensities 
calculated according to the models, using the best values for the 
parameters (open symbols). 
Comparison of the values of D for different models shows 
whether one model is significantly better than another, or whether 
the two fit the experimental data equally well. How well the 
experimental data are fit may also be judged from Figures 3-6 
themselves. Comparison of rate constants helps in understanding 
the physical meaning of the models. Due to the fact that the 
DNase I concentration is expressed in units and the drug con- 
centration in moles per liter, the rate constants for the enzyme 
and drug are not directly comparable. However, comparing the 
ratios of rate constants is valid. It should be noted that the value 
of k i ,  the rate constant for conversion of form 111 DNA to shorter 
fragments, cannot be determined accurately from the data, because 
the data are for low drug concentrations, for which the amount 
of short fragments produced is small. 
DNA Cleavage Mechanism. DNase I. Prior to analyzing the 
cleavage data for esperamicin and calicheamicin using the outlined 
coupled kinetic approach, we analyzed cleavage of PM2 DNA 
by the enzyme DNase I. This enzyme binds and cleaves D N A  
by a well-known mechanism and, under the conditions used in 
the study, should cleave via a single-strand process.*J4 DNase 
I is a 30-kDa protein that hydrolyzes the phosphodiester backbone 
of DNA. Single-crystal X-ray analysis has shown that, when 
DNAse I is bound to DNA, the calcium ion a t  the catalytic site 
of the enzyme is positioned near a phosphate group on one strand 
of DNA.I4 The metal ion acts as a Lewis acid and, when bound 
to the phosphate group, facilitates the hydrolysis of the diester 
linkage of DNA. 
Table I shows that the single-strand model fits much better than 
the double-strand model. The ratio of kl' to k2' for this model 
is -5.4. If the affinities of DNAse I for all three forms of PM2 
DNA were the same and cleavages were completely random on 
both strands, the ratio k l ' / k i  would be expected to be 2 orders 
of magnitude greater than that found. This estimate is based on 
the length of the PM2 DNA genome, 9300 nucleotides, and the 
assumption that the formation of form 111 from form I1 requires 
cleavages on opposing strands, which are within 6-10 base pairs 
of each other. The lower than expected ratio can be due to an  
unusually low value of kl '  and/or a large value of k i .  In other 
studies with radiolabeled restriction fragments in the presence of 
(14) Suck D.; Lahm. A.; Oefner, C. Nature (London) 1988,332,464-468. 
Suck, D.; Oefner, C. Nature (London) 1986, 321, 620-625. 
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of the squared deviations, D, in Table I shows that both models, 
single strand and double strand, fit the data for esp C and cali- 
cheamicin equally well. The fact that both models fit can be 
understood by considering the values of kl’ and kl) for the sin- 
glestrand model. With k; > kl’ in this model, almost every initial 
break in a form I DNA species, converting it to form 11, is quickly 
followed by the conversion of form I1 to form 111. This makes 
the overall process effectively a double-strand or “simultaneous” 
cleavage event: there is very little net production of form I1 
because it is immediately converted to form 111. That this is indeed 
what is happening may be seen by comparing the calculated 
intensities for the two models (dashed lines and open symbols in 
Figures 5 and 6). The curves are practically identical, meaning 
that the single-strand model is equivalent to the double-strand 
model for this choice of parameters. 
Obviously, one cannot conclude that double-strand cleavage 
is occurring to the exclusion of single-strand cleavage. Both 
probably take place, and one could construct a model including 
both processes I - I1 and I - 111. Such a model would have 
an additional parameter (a rate constant). Since the present 
six-parameter models fit the data satisfactorily, fitting to a sev- 
en-parameter model does not seem a reasonable procedure. The 
value of D would certainly decrease, but the values of the pa- 
rameters determined would not be very meaningful. 
In the double-strand cleavage model, the fact that k i  is much 
less than kql implies that the formation of form 111 from form 
I is faster than its formation from form 11. In the single-strand 
cleavage model, the ratio k,’/k,’ reflects the ratio of the rate of 
I1 - 111 to the rate of I - 11, large values of this ratio signifying 
more effective double-strand cleavage. Since kl)/k,’ = 3 for 
esperamicin C and 66 for calicheamicin, we conclude that the latter 
is more efficient at causing double-strand breaks. From the values 
of kl‘ it is also evident that the rate of cleavage of closed circular 
form I DNA by calicheamicin is 1 order of magnitude less than 
that of esperamicin C and almost 2 orders less than that of es- 
peramicin AI. Whether this is due to differences in the cleavage 
rate constants for the compounds or simply a manifestation of 
differing affinities that the agents may have for D N A  remains 
to be determined. However, from the rate data it is clear that 
once calicheamicin cleaves one strand of DNA, cleavage of the 
opposing strand is rapid. 
Although it is not possible to identify the relative locations of 
the two breaks in DNA from the agarose gel studies, earlier work 
using sequencing methods showed that calicheamicin-induced 
breaks are three nucleotides apart and skewed in the 3’-direction 
along the strands4 This indicates that the drug is bound in the 
minor groove and, as has been recently shown in modeling stud- 
ies,I7 with the warhead portion straddling two base pairs of DNA. 
Recent N M R  studies’* have further indicated that the sugars of 
calicheamicin are  “preorganized” and that they adopt a confor- 
mation outside of DNA closely matching that of the minor groove. 
Although less is known about the binding of esperamicin to DNA, 
the skewing in the drugs’ cleavage patterns2 and the ability of 
certain other drugsI6 to influence DNA cleavage by esperamicin 
indicate that this compound also binds in the minor groove. The 
work presented here clearly shows that for esp C the warhead 
portion of the drug is situated such that targets on both strands 
are readily accessible and that double-strand cleavage occurs with 
high probability when compared to esp AI.  It is interesting to 
note that double-strand cleavage occurs with the two compounds 
having a single point of attachment between the oligosaccharide 
and the 1 S-diyn-3-ene chromophore, e.g., esperamicin C and 
calicheamicin. Models (CPK) show that in the case of esperamicin 
A I ,  which has substituents on two positions of the warhead, the 
deoxyfucose and the attached anthranilate residue can be proximal 
to one of the radicals of the phenylene diradical. Although ad- 
ditional model building involving energy minization will be nec- 
a closed circular DNA as a carrier, it  is evident that the affinity 
of DNAse I for the closed circular DNA i s  much less than its 
affinity for linear DNA, e.g., calf thymus DNA.I5 Since the 
enzyme must bind in order to cleave DNA, this suggests that kl’, 
for cleavage of the closed circular form, will be lower than expected 
(due to lower affinity for closed circular DNA). The enzyme may 
also cause some double-strand cleavage of DNA, as has been 
shown to occur in the presence of Mn2+ and Cd+? In the context 
of the single-strand cleavage model this would lead to a higher 
value of kl), thus also lowering the ratio k l ’ / k i .  Although a model 
including both single- and double-strand cleavage could be used, 
it is unnecessary since a simple, single-strand cleavage model 
already fits the data within experimental error. It may be noted 
that k i  and k{ are about the same size, suggesting that the process 
of conversion of form I1 is similar to the process of destruction 
of form 111. 
As shown in Table I and Figure 3, analysis of the data according 
to the double-strand cleavage model leads to a significantly poorer 
fit to the experimental intensities than using the single-strand 
model. This implies that the former model is not applicable and 
DNase I cleaves D N A  primarily via a single-strand cleavage 
process. Further evidence for this conclusion is the appreciable 
negative (and thus unacceptable) value of k; with the double- 
strand cutting model. 
Esperamicin AI .  The single-strand cleavage model fits the data 
for this esperamicin analogue, as shown in Table I and Figure 
4. An attempt to fit them with the double-strand model led to 
a 3-fold increase in the sum of the squared deviations, D, and to 
a substantial negative value of kl), showing that esp A I  is mainly 
a single-strand cleavage agent. The ratio k l ’ / k i  for esp A I  for 
the single-strand model is strikingly similar to that for DNase I 
(Table I). Because of the dramatic differences in structure and 
cleavage mechanism between the drug and the enzyme, this result 
was not expected. Like the enzyme, the drug may have a sig- 
nificantly reduced affinity for the tense form I DNA relative to 
the other two forms, which would lower the value of kl’. Although 
the drugI6 and the enzyme“ both cleave DNA from its minor 
groove, the drug is not likely to be as sensitive as the enzyme to 
the nuances of DNA structure. For example, changes in mi- 
nor-groove width such as would occur between supercoiled form 
I and relaxed forms I1 and 111 DNA would be expected to affect 
drug binding to a lesser extent than enzyme binding. The fact 
that k,’ /k< is lower than expected for random single-strand 
cleavage may also reflect a certain number of double-strand 
cleavages occumng with esp AI. In the context of the singlestrand 
model this would cause a higher value of kl) and lower the ratio 
k l ’ / k i .  DNA cleavage by the drug, unlike the enzyme, is not 
expected to be catalytic. The activation mechanism requires the 
formation of a phenylene diradical that reacts with hydrogen atom 
donors in an irreoersible manner, ultimately forming the aro- 
matized drug esp Z. Esperamicin Z is not capable of cleaving 
DNAm2 
The single-strand cleavage behavior of esp AI means that one 
of the radicals of the phenylene diradical is unproductive with 
regard to a detectable strand break in the assay used. Although 
further study is warranted, it may be that the “silent” radical reacts 
with solvent, the drug itself, or DNA. If the reaction with DNA 
involved the cleaved strand or the opposing strand but the hydrogen 
atom abstraction did not lead to a break in the sugar-phosphate 
backbone of the strand, form I would not convert directly to form 
111 DNA. It may be noted that k i  is much bigger than k i  for 
esp AI.  The reason for this is not understood, but our data show 
that, even a t  the highest esperamicin concentration, the concen- 
tration of form 111 DNA is still rising, which makes the deter- 
mination of k i  from these data problematic. 
bperamicin C and Calicbeamicin. Figures 5 and 6 and Table 
I show that the cleavage behavior of esp C and calicheamicin is 
significantly different from that of esp AI or DNAse I. The sum 
~~ ~~ ~~~~ 
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Doyle, T. W. Proc. Nail. Acad. Sci. U.S.A. 1989, 86, 1612. 
(17) Hawley, R. C.; Kiessling. L. L.; Schreiber, S. L. Proc. Nut/. Acad. 
(18) Walker, S.; Valentine, K. G.; Kahne, D. J .  Am. Chrm. Soc. 1990, 
Sci. U.S.A. 1989. 86, 1105-1109. 
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essary, this suggests that ‘self-quenching” by the drug of one of 
the radicals may be the reason that esp A I  cleaves DNA in a 
single-strand manner. 
Certain of the steps leading to the activation of the warhead 
portion of calicheamicin have recently been investigated by N M R  
methods.I9 The first-order rate constant for the formation of 
aromatized drug from the Michael addition product outside of 
DNA is 5 X lo4 s-l. In addition to being second-order rate 
constants, the k,‘ in Table I involve all of the individual steps 
including drug activation and the processes on DNA leading to 
strand breakage and thus cannot be directly compared with the 
rate constants of microsteps measured by N M R .  
Esperamicin C and calicheamicin are unique in their DNA 
cleavage mechanisms. A single activation event on their chro- 
mophores leads to a double-strand break in DNA. This behavior 
is different from that of neocarzinostatin, which although it breaks 
one strand and modifies the second strand requires posttreatment 
of the DNA in order to produce a double-strand breaks5,’ Since 
(19) De Voss, J. J.; Hangeland. J. J.; Townsend, C. A.; J .  Am. Chem. Soc. 
1990, 112,4554-4556. 
esp A I  is more potent as an antitumor agent than is esp C: single- 
versus double-strand cleavage is not the only factor influencing 
cytotoxicity. Cellular uptake and drug delivery very likely also 
play major roles in determining the biological effectiveness of the 
agents. 
Conclusions 
By using a coupled kinetic model, we studied the ability of 
esperamicin, calicheamicin, and the enzyme DNase I to cause 
single- or double-strand cleavage of DNA. The analysis shows 
that DNase I and esperamicin A, cleave DNA mainly via a 
single-strand process, whereas esperamicin C and calicheamicin 
cleave mainly through a double-strand mechanism. Examination 
of the structure of the drugs shows that the location of the sugars 
on the warhead portion of the agents is a factor influencing single 
versus double-strand cleavage of DNA. 
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Humidity-Controlled Reversible Structure Transition of 
Disodium Adenosine 5’-Triphosphate between Dihydrate and 
Trihydrate in a Single Crystal State 
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Abstract: The humiditycontrolled singlecrystal transition of disodium adenosine 5’-triphosphate (Na2ATP) between the dihydrate 
(1) and trihydrate (2) forms was investigated over the humidity range 5-50% at 23 OC by X-ray analysis. A crystal of 2 formed 
at high humidity changes into 1 at low humidity. The transition is reversible. The crystal structure of 1 was determined to 
be orthorhombic space group P212121 with the cell parameters a = 27.572 (5), b = 21.066 (3), and c = 7.0854 (9) A. The 
structure was solved by direct methods and refined to the final R value of 0.097 for 2450 independent reflections. Two water 
molecules, which are hydrogen-bonded to the hydroxyl groups of riboses in 2, are lost in 1. The triphosphate linkages are 
in helical arrangement, and the adenine bases are highly stacked along the c axis, as for 2. There are two ATP molecules, 
A and B, in an asymmetric unit. The conformation of molecule A in 1 resembles that in 2; the ribose is C3’-endo, and the 
exocyclic C4’45’  torsion is gauche+. In molecule B, the ribose is CY-endo, and the C4%5’ torsion is gauche-, in contrast 
to C2’-endc-C3’-exo, and gauche+ in 2. The torsional angles around the P-0 ester bonds of the triphosphate chains of both 
molecules in 1 differ from those in 2 by 8-47O. Conformational flexibility of ATP makes the single-crystal transition possible. 
The conformation of molecule B in 1 relates to the conformation of ATP in its complexes with enzymes. The crystal structure 
of 2 (Kennard; et al. Proc. R. SOC. London 1971, A325,401-436) was refined to the final R value of 0.1 17 with the newly 
collected data, and the original assignment of Na4 and OW4 was interchanged. 
Introduction 
Adenosine S’-triphosphate (ATP)-enzyme interactions have 
been discussed with regard to the crystal structures of enzyme- 
ATP (or ATP analogue) complexes.’” For example, in a series 
of site-directed mutagenic studies of tyrosyl-tRNA synthetase 
(TyrTS), the crystal structure of the TyrTS-tyrosyl adenylate 
complex was referred to in order to analyze the ATP-TyrTS 
interactions.5 Although the concept of a ‘rigid” nucleotide was 
proposed based on conformational analyses of the crystal structures 
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of nucleotides,6 the adenosine moiety of ATP-enzyme complex 
is sometimes in an “uncommon” conformation; the ribose of the 
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